First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Urothelium

This is a "connection" page, showing publications Karl-Erik Andersson has written about Urothelium.
Connection Strength

1.480
  1. Andersson KE. Mechanisms of ATP release--future therapeutic targets? BJU Int. 2015 Jun; 115(6):850-1.
    View in: PubMed
    Score: 0.438
  2. Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013 Apr; 93(2):653-80.
    View in: PubMed
    Score: 0.377
  3. Birder LA, Andersson KE, Kanai AJ, Hanna-Mitchell AT, Fry CH. Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013. Neurourol Urodyn. 2014 Jun; 33(5):597-601.
    View in: PubMed
    Score: 0.102
  4. Sunagawa M, Wolf-Johnston A, Nomiya M, Sawada N, Andersson KE, Hisamitsu T, Birder LA. Urinary bladder mucosal responses to ischemia. World J Urol. 2015 Feb; 33(2):275-80.
    View in: PubMed
    Score: 0.101
  5. Limberg BJ, Andersson KE, Aura Kullmann F, Burmer G, de Groat WC, Rosenbaum JS. ß-Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res. 2010 Nov; 342(2):295-306.
    View in: PubMed
    Score: 0.080
  6. Andersson KE, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int. 2010 Oct; 106(8):1114-27.
    View in: PubMed
    Score: 0.079
  7. Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol. 2010 Jun; 57(6):1093-100.
    View in: PubMed
    Score: 0.076
  8. Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009 Nov; 56(5):810-9.
    View in: PubMed
    Score: 0.073
  9. Andersson KE, Fullhase C, Soler R. Urothelial effects of oral agents for overactive bladder. Curr Urol Rep. 2008 Nov; 9(6):459-64.
    View in: PubMed
    Score: 0.069
  10. Andersson KE, Hedlund P. Pharmacologic perspective on the physiology of the lower urinary tract. Urology. 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1.
    View in: PubMed
    Score: 0.046
  11. Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S. Researching bladder afferents-determining the effects of ß(3) -adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn. 2011 Jun; 30(5):684-91.
    View in: PubMed
    Score: 0.021
  12. Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008 Nov; 180(5):2226-33.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.